MarginsXMarginsX
Home › Markets › Industrials › BNGO

Bionano Genomics Inc. (BNGO)

BNGO trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.9400
-6.00% on the day
Market cap
$13.1M
Nano cap
Revenue · 2025
$28.5M
-7.4% on 2024
Net income · 2025
-$26.4M
-92.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1411690/000141169026000007/0001411690-26-000007-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBNGO on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year2018
SEC CIK0001411690
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$28.5M
Net income-$26.4M
Operating income-$33.3M
Net margin-92.6%
Operating margin-116.9%
Revenue growth-7.4%
Cash$3.0M
Total assets$73.6M
P/E (computed)Net income was not positive
P/S (computed)0.5×

Warning signs

Cash runway
2.7 months
$4.4M cash at September 30, 2026
Share count, 1 year
+37.5%
2025-11-05 to 2026-11-04 · +2061.0% over 3 years
Going-concern doubt
Yes
10-Q filed November 10, 2026
Insider net buying, 12 months
$10K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Management has prepared cash flows forecasts which indicate that based on the Company's expected operating losses and negative cash flows, there is substantial doubt about the Company's ability to continue as a going concern within twelve months after the date that the unaudited condensed consolidated financial statements for the nine months ended September 30, 2026, are issued."
10-Q 2026-11-10
Cash and burn$4.4M cash; operating cash flow -$4.8M a quarter.Report 2026-09-30
Shares outstanding13,989,000 (2026-11-04); 10,176,000 a year earlier; 38,840,337 three years earlier. 3y figure adjusted for splits (1-for-60 overall).Cover page 2026-11-04
Reverse splits, 3 years1; latest 1-for-60 on 2025-01-27Source 2025-01-27
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-05-08
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBDO USA, P.C., San Diego, California, United StatesPCAOB Form AP 2026-03-25
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $10K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$8.3M-$6.5M-$4.5M$4.4MNo debt tags$31.1M10-Q 2026-11-10
Q2 2026
2026-06-30
$8.2M-$7.4M-$4.7M$3.7MNo debt tags$30.2M10-Q 2026-08-10
Q1 2026
2026-03-31
$6.7M-$8.3M-$5.7M$3.4MNo debt tags$28.7M10-Q 2026-05-13
Q4 2025
2025-12-31
$8.0M-$7.9M-$4.2M$3.0MNo debt tags$28.5M10-K 2026-03-23
Q3 2025
2025-09-30
$7.4M-$8.5M-$5.9M$3.1MNo debt tags$28.7M10-Q 2026-11-10
Q2 2025
2025-06-30
$6.7M-$6.9M-$3.5M$3.6MNo debt tags$27.4M10-Q 2026-08-10
Q1 2025
2025-03-31
$6.5M-$3.1M-$2.8M$3.6MNo debt tags$28.5M10-Q 2026-05-13
Q4 2024
2024-12-31
$8.2M-$20.1M-$6.5M$9.2MNo debt tags$30.8M10-K 2026-03-23

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-11-05
Latest annual report10-K2026-03-23
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-10
Latest proxyDEFA14A2026-04-02

Source: SEC EDGAR submissions feed, 634 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-13.0%
1 month-26.5%
3 months-15.3%
Year to date-34.6%
1 year-32.0%
From 52-week high-45.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
CIRCCircle8 Group Inc.$0.1702-7.30%$20.0M
ASTCAstrotech Corporation (DE)$3.76-10.48%$8.0M
EYPTEyePoint Inc.$0.3076+0.52%$35.0M
PRPOPrecipio Inc.$19.96-9.81%$35.8M
RPIDRapid Micro Biosystems Inc.$0.7400+13.67%$37.1M
HBIOHarvard Bioscience Inc.$8.91-5.96%$40.7M
SEERSeer Inc.$1.48-5.73%$82.6M
QTRXQuanterix Corporation$2.84-3.07%$134.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier